Cancer News and Research

RSS

Cancer begins in your cells, which are the building blocks of your body. Normally, your body forms new cells as you need them, replacing old cells that die. Sometimes this process goes wrong. New cells grow even when you don't need them, and old cells don't die when they should. These extra cells can form a mass called a tumor. Tumors can be benign or malignant. Benign tumors aren't cancer while malignant ones are. Cells from malignant tumors can invade nearby tissues. They can also break away and spread to other parts of the body.

New method to synthesize cancer-fighting phytochemicals

Phytoalexins have attracted a great deal of interest because of their major role in plant health and their health-promoting effects in humans.

26 Jun 2020

Helping to unravel the genetic diversity of cancer tumors

The ability to sequence the genome of a tumor has revolutionized cancer treatment over the years by identifying drivers of cancer at the molecular level.

26 Jun 2020

Scientists study how cancer cells in the liver react to magnetic nanoparticles

Scientists from the Immanuel Kant Baltic Federal University and National University of Science and Technology "MISiS" have studied how magnet nanoparticles affect cancer cells in the human liver.

26 Jun 2020

Molecular dynamic simulations may contribute to structure-based drug design

Uppsala University scientists have reported that they have developed a new way to predict how unique molecules that can be employed in novel immunotherapy.

26 Jun 2020

Lesion segregation can drive complex patterns of mutations in tumor genomes

Researchers from the German Cancer Research Center, Cambridge, and Edinburgh have been analyzing the evolution of tumors after chemical damage.

26 Jun 2020

Study identifies complex functional, physical interactions between p53 gene and the INSR pathway

Volume 11, Issue 25 of @Oncotarget reported that the present study was aimed at evaluating the hypothesis that p53 governs the expression and activation of the INSR gene in breast cancer cells.

25 Jun 2020

A metabolic enzyme could be a potential drug target for B cell lymphomas

Scientists at the Sloan Kettering Institute have found that increased activity of a normal metabolic enzyme can lead to cancer.

25 Jun 2020

Researchers discover new druggable pathway linked with tuberous sclerosis

Tuberous sclerosis complex (TSC) is a neurological disorder causing non-cancerous tumors, called cortical tubers, to grow throughout the brain and body, as well as other conditions like epilepsy and autism.

25 Jun 2020

Whole genome sequencing can improve rare disease diagnosis

A research programme pioneering the use of whole genome sequencing in the NHS has diagnosed hundreds of patients and discovered new genetic causes of disease.

25 Jun 2020

Subtypes in alzheimer's disease may be linked to tau protein modifications

A new study reveals a possible biological reason that Alzheimer's Disease (AD) progresses at different rates in different patients.

25 Jun 2020

Short-term exposure to low levels of air pollution can affect gene expression

New data from a landmark study by Monash University researchers raises concerns that even short-term exposure to low level air pollution can affect gene expression, leaving us at risk of diseases such as cancer, cardiovascular and respiratory diseases.

25 Jun 2020

Study shows how chemicals cause complex cell mutations

Fresh insights into why some harmful substances are so efficient at causing cancer could aid the quest for better treatments.

25 Jun 2020

Blocking A 'Jamming Signal' Can Unleash Immune System To Fight Tumors

Yale researchers have discovered a "jamming signal" that blocks a powerful immune system stimulant called interleukin-18 (IL-18) from reaching tumors.

25 Jun 2020

Experts identify steps to expand, improve SARS-CoV-2 serology tests

More than 300 scientists and clinicians from the federal government, industry and academia published a report of their conclusions and recommendations on COVID-19 serology studies online in Immunity.

24 Jun 2020

Chemist Develops Potential Drug To Treat Type 2 Diabetes Without Harsh Side Effects

Professor Dr. Robert P. Doyle has developed a new drug to treat type 2 diabetes in millions of patients who are seeking to better control their blood sugar.

24 Jun 2020

CAR T Cell Therapy: Potential For Considerable Savings

CAR T cell therapy is a new and, in some cases, highly effective form of immunotherapy to treat certain types of cancer of the blood and lymph system.

24 Jun 2020

Research unravels molecular circuitry that controls cancer growth and spread

Research led by Queen Mary University of London has revealed novel insights into the molecular circuitry controlling cancer cell growth and spread. The findings highlight new pathways involved in these key processes of cancer progression that may represent targets for therapies.

24 Jun 2020